Allianz Asset Management
CTSO icon

Allianz Asset Management’s Cytosorbents Corp CTSO Stock Holding History

Allianz Asset Management’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-131,472
Closed -$661K – 2775
2019
Q3 		$661K Sell
131,472
-198,614
-60% -$1.16M ﹤0.01% 2281
2019
Q2 		$2.18M Sell
330,086
-2,784
-0.8% -$19.1K ﹤0.01% 1850
2019
Q1 		$2.52M Sell
332,870
-3,762
-1% -$29.3K ﹤0.01% 1761
2018
Q4 		$2.72M Sell
336,632
-13,546
-4% -$135K ﹤0.01% 1642
2018
Q3 		$4.52M Buy
350,178
+92,508
+36% +$1.16M ﹤0.01% 1608
2018
Q2 		$2.94M Buy
+257,670
New +$2.44M ﹤0.01% 1774

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

Allianz Asset Management's CTSO Position: Q4 2019 in Review

Allianz Asset Management sold out of Cytosorbents Corp (CTSO) in Q4 2019, closing a stake of 131,472 shares — an estimated $661K sold.

Allianz Asset Management first reported a position in CTSO in Q2 2018 and held it in 6 quarters. The position peaked at $4.52M in Q3 2018. 72 funds tracked by Wall St. Rank hold CTSO as of Q4 2019.

  • Allianz Asset Management reported no remaining Cytosorbents Corp position as of Q4 2019 after selling out during the quarter.
  • Allianz Asset Management sold 131,472 Cytosorbents Corp shares in Q4 2019, an estimated $661K.
  • Allianz Asset Management first reported a position in Cytosorbents Corp in Q2 2018 and held it in 6 quarters.
  • Allianz Asset Management's Cytosorbents Corp position peaked at $4.52M in Q3 2018.
  • 72 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2019.

Based on Allianz Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.